Distribution and characteristics of Escherichia coli clonal group A

被引：64
作者：
Johnson, JR
Murray, AC
Kuskowski, MA
Schubert, S
Prère, MF
Picard, B
Colodner, R
Raz, R
机构：
[1] Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany
[4] Ctr Hosp Univ Purpan, Toulouse, France
[5] Hop Morvan, Brest, France
[6] HaEmek Med Ctr, Afula, Israel
[7] Techn Sch Med, Afula, Israel
来源：
EMERGING INFECTIOUS DISEASES | 2005年 / 11卷 / 01期
关键词：
D O I：
10.3201/eid1101.040418
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim-sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.
引用
收藏
页码：141 / 145
页数：5
相关论文
共 15 条
  • [1] Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates
    Burman, WJ
    Breese, PE
    Murray, BE
    Singh, KV
    Batal, HA
    MacKenzie, TD
    Ogle, JW
    Wilson, ML
    Reves, RR
    Mehler, PS
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (05) : 358 - 364
  • [2] Rapid and simple determination of the Escherichia coli phylogenetic group
    Clermont, O
    Bonacorsi, S
    Bingen, E
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (10) : 4555 - 4558
  • [3] Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction
    Enne, VI
    Livermore, DM
    Stephens, P
    Hall, LMC
    [J]. LANCET, 2001, 357 (9265) : 1325 - 1328
  • [4] Rapid and specific detection of Escherichia coli clonal group a by gene-specific PCR
    Johnson, JR
    Owens, K
    Manges, AR
    Riley, LW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) : 2618 - 2622
  • [5] Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans
    Johnson, JR
    Kuskowski, MA
    Owens, K
    Gajewski, A
    Winokur, PL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (05) : 759 - 768
  • [6] Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products
    Johnson, JR
    Murray, AC
    Gajewski, A
    Sullivan, M
    Snippes, P
    Kuskowski, MA
    Smith, KE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2161 - 2168
  • [7] Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections
    Johnson, JR
    Russo, TA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (06) : 859 - 864
  • [8] A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis
    Johnson, JR
    Manges, AR
    O'Bryan, TT
    Riley, LW
    [J]. LANCET, 2002, 359 (9325) : 2249 - 2251
  • [9] Clonal origin, virulence factors, and virulence
    Johnson, JR
    Kuskowski, M
    [J]. INFECTION AND IMMUNITY, 2000, 68 (01) : 424 - 425
  • [10] Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis
    Manges, AR
    Dietrich, PS
    Riley, LW
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 329 - 334
12